IRIS
SIGHINOLFI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.405
EU - Europa 445
AS - Asia 116
AF - Africa 14
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 1.993
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.397
IT - Italia 151
SE - Svezia 128
VN - Vietnam 81
PL - Polonia 52
DE - Germania 23
GB - Regno Unito 20
CN - Cina 16
FR - Francia 13
CZ - Repubblica Ceca 12
RU - Federazione Russa 12
ZA - Sudafrica 9
CA - Canada 8
IN - India 8
UA - Ucraina 7
IE - Irlanda 6
BR - Brasile 4
CL - Cile 4
DK - Danimarca 4
FI - Finlandia 4
JP - Giappone 4
NL - Olanda 4
AE - Emirati Arabi Uniti 3
LT - Lituania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
CH - Svizzera 2
AL - Albania 1
BE - Belgio 1
BJ - Benin 1
BT - Bhutan 1
CM - Camerun 1
HU - Ungheria 1
IL - Israele 1
KR - Corea 1
NG - Nigeria 1
PE - Perù 1
PT - Portogallo 1
TH - Thailandia 1
TZ - Tanzania 1
ZW - Zimbabwe 1
Totale 1.993
Salva come PNG Salva come JPEG
Città #
Santa Cruz 252
Stockholm 126
Fairfield 112
Dong Ket 81
Ashburn 76
Seattle 75
Woodbridge 66
Des Moines 58
Houston 52
Warsaw 52
Buffalo 41
Castello Di Fiemme 33
Chicago 33
Cambridge 31
Wilmington 28
Ferrara 27
Ann Arbor 24
San Diego 21
Santa Maria Di Sala 17
Los Angeles 16
New York 15
Las Vegas 12
Dallas 9
Rome 8
Henderson 7
Saint Petersburg 7
San Jose 7
Dublin 6
Paris 6
Provo 6
Bengaluru 5
Lake Forest 5
Muizenberg 5
Providence 5
Boulder 4
Clearwater 4
Guangzhou 4
Milan 4
Rosolina 4
Scranton 4
Toronto 4
Brooklyn 3
Crugers 3
Helsinki 3
Herndon 3
Lyngby 3
Reston 3
Shanghai 3
Adelaide 2
Atlanta 2
Auburn 2
Boardman 2
Cedar Knolls 2
Chandler 2
Chennai 2
Cheyenne 2
Denver 2
Dulles 2
Durban 2
Fleming Island 2
Hamburg 2
Hefei 2
Irpin 2
Jacksonville 2
Lincoln 2
Lombard 2
Manchester 2
Miami 2
Mountain View 2
New Orleans 2
Omaha 2
Palermo 2
Portland 2
Riva 2
San Francisco 2
San Mateo 2
Saronno 2
Valeggio sul Mincio 2
Yellow Springs 2
Abano Terme 1
Andover 1
Aurora 1
Austin 1
Bangalore 1
Bangkok 1
Barrie 1
Bartlesville 1
Bologna 1
Boston 1
Brockport 1
Büdelsdorf 1
Carrollton 1
Changzhi 1
Columbus 1
Curitiba 1
Deiva Marina 1
Egg Harbor City 1
Elk Grove Village 1
Ferrara di Monte Baldo 1
Frankfurt Am Main 1
Totale 1.456
Salva come PNG Salva come JPEG
Nome #
Drop in CD4+ Counts Below 200 Cells/μL After Reaching (or Starting From) Values Higher than 350 Cells/μL in HIV-Infected Patients With Virological Suppression, file e309ade2-cc68-3969-e053-3a05fe0a2c94 136
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART, file e309ade2-c8f7-3969-e053-3a05fe0a2c94 94
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV, file e309ade2-cb76-3969-e053-3a05fe0a2c94 93
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART, file e309ade2-d399-3969-e053-3a05fe0a2c94 93
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients, file e309ade2-c8f2-3969-e053-3a05fe0a2c94 83
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014, file e309ade2-d217-3969-e053-3a05fe0a2c94 75
Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: The D: A: D study, file e309ade2-d3a6-3969-e053-3a05fe0a2c94 73
HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients, file e309ade2-c530-3969-e053-3a05fe0a2c94 71
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort, file e309ade2-d046-3969-e053-3a05fe0a2c94 68
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort, file e309ade2-d360-3969-e053-3a05fe0a2c94 68
Inflammatory effects of atazanavir/ritonavir versus darunavir/ritonavir in treatment naïve, HIV-1-infected patients, file e309ade2-c109-3969-e053-3a05fe0a2c94 66
Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients, file e309ade2-c6af-3969-e053-3a05fe0a2c94 61
Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing, file e309ade2-c57b-3969-e053-3a05fe0a2c94 59
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort, file e309ade2-d39b-3969-e053-3a05fe0a2c94 58
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: data from the Icona cohort, file e309ade2-c5f3-3969-e053-3a05fe0a2c94 56
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study, file e309ade2-d39a-3969-e053-3a05fe0a2c94 56
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort, file e309ade2-cb06-3969-e053-3a05fe0a2c94 55
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy, file e309ade2-d032-3969-e053-3a05fe0a2c94 55
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus, file e309ade2-d555-3969-e053-3a05fe0a2c94 55
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study, file e309ade2-ca75-3969-e053-3a05fe0a2c94 54
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D study, file e309ade2-d3cb-3969-e053-3a05fe0a2c94 54
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice, file e309ade2-d556-3969-e053-3a05fe0a2c94 54
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort, file e309ade2-d3d4-3969-e053-3a05fe0a2c94 51
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy, file e309ade2-c879-3969-e053-3a05fe0a2c94 50
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?, file e309ade2-cbd4-3969-e053-3a05fe0a2c94 50
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy, file e309ade2-cd76-3969-e053-3a05fe0a2c94 47
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus, file e309ade2-c8f6-3969-e053-3a05fe0a2c94 45
A Comparison Between Different Anti-Retroviral Therapy Regimes on Soluble Inflammation Markers: a Pilot Study, file e309ade2-c2b5-3969-e053-3a05fe0a2c94 42
Evaluation of HIV Transmission Clusters among Natives and Foreigners Living in Italy, file e309ade4-d546-3969-e053-3a05fe0a2c94 37
Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation, file e309ade1-b2b9-3969-e053-3a05fe0a2c94 34
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison, file e309ade2-cc69-3969-e053-3a05fe0a2c94 33
Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort Study, file e309ade2-dde1-3969-e053-3a05fe0a2c94 26
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL, file e309ade2-cb0e-3969-e053-3a05fe0a2c94 17
null, file e309ade2-c65b-3969-e053-3a05fe0a2c94 15
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV, file e309ade2-dea4-3969-e053-3a05fe0a2c94 15
Virological response and retention in care according to time of starting ART in Italy: data from the Icona Foundation Study cohort, file e309ade4-85e5-3969-e053-3a05fe0a2c94 14
COVID-19 in eastern Emilia: an unusual epidemiology in Northern Italy, file e309ade2-bd27-3969-e053-3a05fe0a2c94 11
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen, file e309ade2-dddf-3969-e053-3a05fe0a2c94 9
Real-life use of elbasvir/grazoprevir in adults and elderly patients: a prospective evaluation of comedications used in the PITER cohort, file e309ade4-9662-3969-e053-3a05fe0a2c94 9
Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress?, file 73c00d70-a72c-41d2-8988-3535910bf388 7
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort, file c6ffdf39-4b54-4a65-a968-37961066a163 3
Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort Study, file e309ade2-c5ff-3969-e053-3a05fe0a2c94 2
Durability and tolerability of first-line regimens including two nucleoside reverse transcriptase inhibitors and raltegravir or ritonavir boosted-atazanavir or -darunavir: data from the ICONA Cohort *, file e309ade2-c6d3-3969-e053-3a05fe0a2c94 2
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen, file e309ade2-c6d8-3969-e053-3a05fe0a2c94 2
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison, file e309ade2-cc6a-3969-e053-3a05fe0a2c94 2
Inflammatory effects of atazanavir/ritonavir versus darunavir/ritonavir in treatment naïve, HIV-1-infected patients, file e309ade4-e80c-3969-e053-3a05fe0a2c94 1
Totale 2.061
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.778
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.778
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 1 0 0 0 0 0 0 0 0
2020/2021531 0 0 0 29 127 60 35 48 29 60 24 119
2021/2022729 36 25 19 23 56 39 56 60 46 48 242 79
2022/2023696 17 31 193 102 27 55 56 108 38 23 28 18
2023/2024104 22 36 46 0 0 0 0 0 0 0 0 0
Totale 2.061